June 2015

Human immunodeficiency virus (HIV) in Washington, D.C.: Prevalence of antiretroviral resistance in treatment naïve patients from 2007 to 2010

HIV treatment has been greatly impacted by transmitted resistance to antiretrovirals (ARV). Several studies have documented resistance in naïve individuals and estimates of transmitted drug resistance mutations range from <5% to as high as 25%.  Washington, D.C. has one of the highest human immunodeficiency virus (HIV) prevalence rates in the United States (3.2% in 2009), but local data regarding the...

Author(s): Matthew J. Swierzbinski, Virginia L. Kan, and David M. Parenti  

June 2015

Impact of information leaflet on human immunodeficiency virus (HIV) related information and self management in HIV positive adolescents

This study evaluates the effectiveness of a peer support intervention on human immunodeficiency virus (HIV) related information and self-management in HIV positive adolescents. Adolescents in this study referred to children in the age group 11 to 16 years. An intervention study, with outcomes assessed the intervention and immediately post-intervention.  Participants aged 11 to 16 years (N = 114) were recruited from...

Author(s): J. Anitha Menon, Kusanthan Thankian and Sidney O.C. Mwaba